Carmat SA Earnings Estimate

Carmat SA Earnings per Share Projection vs Actual

About Carmat SA Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Carmat SA earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Carmat SA estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Carmat SA fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT EO operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 119 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Carmat Stock

Carmat SA financial ratios help investors to determine whether Carmat Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carmat with respect to the benefits of owning Carmat SA security.